SST-001

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameSST-001
Drug Alias NameSST001SST-00118F-FD4
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radionuclide Drug ConjugatesSmall molecules > Heterocyclic drugs +[4] 
Mechanisms of ActionPositron-emission tomography enhancersSynuclein alpha binders
TargetsSynuclein alpha
Therapy Area/IndicationsDiagnostic agentsSynucleinopathiesParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSynuSight Biotech (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSynuSight Biotech (Shanghai) Co LtdABLi Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiagnostic agentsSynucleinopathiesParkinson Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A